Theratechnologies Announces End of Patient Treatment for Phase III Ibalizumab Trial - Seite 2

Forward-Looking Information

This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management's belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as "may", "will", "should", "could", "would", "outlook", "believe", "plan", "envisage", "anticipate", "expect" and "estimate", or the negatives of these terms, or variations of them. The forward-looking statements contained in this press release include, but are not limited to, the timing to complete the analysis of the data resulting from the study and the timing to present the primary end point data of the study.

Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Theratechnologies' control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. These assumptions include but are not limited to, the following: no delay will occur in the analysis of the data related to the study, the data resulting from the study will meet the specifications of the study to allow the filing of a BLA with the FDA and the FDA will not request additional studies.These risks and uncertainties include, but are not limited to, the risk that the results do not meet the criteria sought to file a BLA, that delays occur in the analysis of the data related to the study, or that the FDA requires additional studies.

We refer potential investors to the "Risk Factors" section of our Annual Information Form (AIF) dated February 24, 2016 for additional information about the risk and uncertainties relating to Theratechnologies. The AIF is available on SEDAR at www.sedar.com. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

EXOCET Public Relations inc.
Denis Boucher
514-913-1957